Table 1.
Condition | |||
---|---|---|---|
Placebo | Gelatin | Enteric | |
RPE (AU) | |||
1-km | 11.6 ± 1.9 | 11.5 ± 2.8 | 12.5 ± 2.0 |
2-km | 13.3 ± 2.2 | 12.4 ± 2.5 | 14.0 ± 1.7a |
3-km | 14.8 ± 2.2a | 13.8 ± 1.8 | 15.2 ± 2.1a |
4-km | 16.6 ± 2.3a | 16.0 ± 2.8a | 16.6 ± 2.2a |
RPE-L (AU) | |||
1-km | 13.5 ± 2.7 | 13.6 ± 2.2 | 13.7 ± 2.1 |
2-km | 14.7 ± 2.5 | 14.6 ± 2.2a | 15.0 ± 1.7 |
3-km | 16.1 ± 1.9a | 15.9 ± 2.0a | 16.2 ± 1.6a |
4-km | 17.3 ± 2.4 | 17.8 ± 1.7* | 18.0 ± 2.1* |
ROF (AU) | |||
1-km | 3.9 ± 1.8 | 3.2 ± 1.3 | 3.5 ± 1.1 |
2-km | 5.0 ± 1.4a | 4.7 ± 0.9a | 5.2 ± 1.0a |
3-km | 5.8 ± 1.1a | 5.4 ± 1.2 | 6.2 ± 1.3 |
4-km | 7.5 ± 1.3a | 6.6 ± 1.2a | 7.5 ± 1.4a |
*significant difference from the previous timepoint (P < 0.05)